With a general bullishness amongst the heavyweights, specific money managers were breaking ground themselves. Iguana Healthcare Management, managed by Stuart Weisbrod, initiated the most valuable position in Marinus Pharmaceuticals Inc (NASDAQ:MRNS). Iguana Healthcare Management had $0.6 million invested in the company at the end of the quarter. William Leland Edwards’s Palo Alto Investors also made a $0.5 million investment in the stock during the quarter. The following funds were also among the new MRNS investors: Peter Muller’s PDT Partners and Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.
Let’s check out hedge fund activity in other stocks similar to Marinus Pharmaceuticals Inc (NASDAQ:MRNS). We will take a look at Pure Cycle Corporation (NASDAQ:PCYO), Energy Focus Inc (PINK:EFOI), TRACON Pharmaceuticals Inc (NASDAQ:TCON), and Xenon Pharmaceuticals Inc (NASDAQ:XENE). This group of stocks’ market values are similar to MRNS’s market value.
|Ticker||No of HFs with positions||Total Value of HF Positions (x1000)||Change in HF Position|
As you can see these stocks had an average of 6.75 hedge funds with bullish positions and the average amount invested in these stocks was $22 million. That figure was $5 million in MRNS’s case. Pure Cycle Corporation (NASDAQ:PCYO) is the most popular stock in this table. On the other hand TRACON Pharmaceuticals Inc (NASDAQ:TCON) is the least popular one with only 5 bullish hedge fund positions. Marinus Pharmaceuticals Inc (NASDAQ:MRNS) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard PCYO might be a better candidate to consider a long position.